Conduit Pharmaceuticals所有資訊

3：首次持股聲明-股東 Nirland Ltd

08/14 04:35

SC 13G/A：超過5%持股股東披露文件(修正)-Nirland Limited(14.8%),Stockton Limited(14.8%)等

08/14 04:33

4：持股變動聲明-董事 Farley Chele Chiavacci

06/12 05:58

4：持股變動聲明-高管 Bligh James

06/12 05:58

4：持股變動聲明-高管 Sragovicz Adam

05/16 10:26

4：持股變動聲明-董事 McNealey Jennifer Isacoff

05/16 04:55

4：持股變動聲明-董事 Farley Chele Chiavacci

04/25 05:06

4：持股變動聲明-董事 Lewis-Hall Freda C

04/25 05:06

4：持股變動聲明-高管 Tapolczay David

04/25 05:05

Conduit Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Polar Asset Management Partners Inc.(1.3%)

02/13 01:56

Conduit Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Saba Capital Management, L.P.(0%),Boaz R. Weinstein(0%)等

02/09 02:21

Conduit Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Hudson Bay Capital Management LP(0.10%),Sander Gerber(0.10%)

02/03 05:33

Conduit Pharmaceuticals | 4：持股變動聲明-董事 Lewis-Hall Freda C

2023/12/15 06:16

Conduit Pharmaceuticals | 4：持股變動聲明-董事 Bligh James

2023/12/06 06:20

Conduit Pharmaceuticals | 4：持股變動聲明-董事 Farley Chele Chiavacci

2023/12/06 06:20

Conduit Pharmaceuticals | 4：持股變動聲明-董事 McNealey Jennifer Isacoff

2023/12/06 06:20

Conduit Pharmaceuticals | 4：持股變動聲明-董事 Charles Faith L.

2023/12/06 06:20

Conduit Pharmaceuticals | 4：持股變動聲明-董事 Tapolczay David

2023/12/06 06:20

Conduit Pharmaceuticals | 4：持股變動聲明-首席財務官 Sragovicz Adam

2023/12/06 06:20

Conduit Pharmaceuticals | SC 13G：超過5%持股股東披露文件-Nirland Limited(8.8%),Stockton Limited(8.8%)等

2023/10/03 04:30